Company · CIK 0001497253 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
VivoSim Labs, INC. · VIVS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 PForm 4 → | Sep 1, 4:01 pm EDT | Tony Serge LialinChief Commercial Officer | 10,000 | $0.2804 | $2,804 | 10,000 | — | |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:55 pm EST | Craig KussmanChief Financial Officer | 16,215 | $1.07 | $17,280 | 316,888 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:54 pm EST | Paul GallantGeneral Manager | 10,410 | $1.07 | $11,094 | 210,109 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:53 pm EST | Taylor CrouchCEO & President, Director | 5,665 | $1.07 | $6,037 | 158,879 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:52 pm EST | Jennifer BushGeneral Counsel & Secretary | 13,520 | $1.07 | $14,408 | 268,068 | — | plan? |
| Nov 16, 2018 FForm 4 → | Nov 20, 5:48 pm EST | Sharon Collins PresnellChief Scientific Officer | 11,200 | $1.07 | $11,954 | 280,993 | — | plan? |
| Nov 16, 2018 FForm 4 → | Nov 20, 5:46 pm EST | Craig KussmanChief Financial Officer | 14,720 | $1.07 | $15,711 | 333,103 | — | plan? |
| Nov 16, 2018 FForm 4 → | Nov 20, 5:45 pm EST | Paul GallantGeneral Manager | 9,450 | $1.07 | $10,086 | 220,519 | — | plan? |
| Nov 16, 2018 FForm 4 → | Nov 20, 5:42 pm EST | Taylor CrouchCEO & President, Director | 5,140 | $1.07 | $5,486 | 164,544 | — | plan? |
| Nov 16, 2018 FForm 4 → | Nov 20, 5:40 pm EST | Jennifer BushGeneral Counsel & Secretary | 11,915 | $1.07 | $12,717 | 281,588 | — | plan? |
| Nov 8, 2018 SForm 4 → | Nov 13, 5:17 pm EST | Sharon Collins PresnellChief Scientific Officer | 40,000 | $1.27 | $50,800 | 292,193 | −12.0% | plan? late |
| Aug 16, 2018 FForm 4 → | Aug 16, 7:03 pm EDT | Sharon Collins PresnellChief Scientific Officer | 11,655 | $1.11 | $12,908 | 332,193 | — | plan? |
| Aug 16, 2018 FForm 4 → | Aug 16, 7:02 pm EDT | Craig KussmanChief Financial Officer | 15,320 | $1.11 | $16,967 | 347,823 | — | plan? |
| Aug 16, 2018 FForm 4 → | Aug 16, 7:01 pm EDT | Paul GallantGeneral Manager | 9,835 | $1.11 | $10,892 | 229,969 | — | plan? |
| Aug 16, 2018 FForm 4 → | Aug 16, 7:00 pm EDT | Taylor CrouchCEO & President, Director | 5,350 | $1.11 | $5,925 | 169,684 | — | plan? |
| Aug 16, 2018 FForm 4 → | Aug 16, 6:58 pm EDT | Jennifer BushGeneral Counsel & Secretary | 12,400 | $1.11 | $13,733 | 293,503 | — | plan? |
| Aug 14, 2018 AForm 4 → | Aug 15, 7:04 pm EDT | Steven George HughesChief Medical Officer | 160,714 | — | — | 160,714 | — | plan? |
| Jun 22, 2018 AFForm 4 → | Jun 26, 5:00 pm EDT | Taylor CrouchCEO & President, Director | 57,254 | $1.43 | $22,194 | 175,034 | — | plan? |
| May 24, 2018 AForm 4 → | May 29, 5:44 pm EDT | Sharon Collins PresnellChief Scientific Officer | 74,380 | — | — | 343,848 | — | plan? |
| May 24, 2018 AForm 4 → | May 29, 5:42 pm EDT | Craig KussmanChief Financial Officer | 74,380 | — | — | 363,143 | — | plan? |
| May 24, 2018 AForm 4 → | May 29, 5:39 pm EDT | Paul GallantGeneral Manager | 66,115 | — | — | 239,804 | — | plan? |
| May 24, 2018 AForm 4 → | May 29, 5:37 pm EDT | Taylor CrouchCEO & President, Director | 148,760 | — | — | 148,760 | — | plan? |
| May 24, 2018 AForm 4 → | May 29, 5:36 pm EDT | Jennifer BushGeneral Counsel & Secretary | 70,248 | — | — | 305,903 | — | plan? |
| May 16, 2018 FForm 4 → | May 17, 5:42 pm EDT | Sharon Collins PresnellChief Scientific Officer | 8,325 | $1.66 | $13,837 | 269,468 | — | plan? |
| May 16, 2018 FForm 4 → | May 17, 5:41 pm EDT | Craig KussmanChief Financial Officer | 11,720 | $1.66 | $19,480 | 288,763 | — | plan? |
| May 16, 2018 FForm 4 → | May 17, 5:40 pm EDT | Paul GallantGeneral Manager | 6,890 | $1.66 | $11,452 | 173,689 | — | plan? |
| May 16, 2018 FForm 4 → | May 17, 5:39 pm EDT | Jennifer BushGeneral Counsel & Secretary | 9,160 | $1.66 | $15,225 | 235,655 | — | plan? |
| Feb 16, 2018 FForm 4 → | Feb 20, 8:54 am EST | Sharon Collins PresnellChief Scientific Officer | 9,420 | $1.09 | $10,225 | 277,793 | — | plan? |
| Feb 16, 2018 FForm 4 → | Feb 20, 8:53 am EST | Craig KussmanChief Financial Officer | 13,265 | $1.09 | $14,399 | 300,483 | — | plan? |
| Feb 16, 2018 FForm 4 → | Feb 20, 8:51 am EST | Paul GallantGeneral Manager | 7,820 | $1.09 | $8,489 | 180,579 | — | plan? |
| Feb 16, 2018 FForm 4 → | Feb 20, 8:50 am EST | Jennifer BushGeneral Counsel & Secretary | 10,365 | $1.09 | $11,251 | 244,815 | — | plan? |
| Nov 22, 2017 PForm 4 → | Dec 4, 9:00 am EST | Keith MurphyOther | 335,500 | $1.49 | $501,307 | 6,373,673 | +5.56% | plan? late |
| Nov 16, 2017 FForm 4 → | Nov 16, 7:49 pm EST | Sharon Collins PresnellChief Scientific Officer | 5,860 | $1.47 | $8,615 | 287,213 | — | plan? |
| Nov 16, 2017 FForm 4 → | Nov 16, 7:48 pm EST | Craig KussmanChief Financial Officer | 11,890 | $1.47 | $17,481 | 313,748 | — | plan? |
| Nov 16, 2017 FForm 4 → | Nov 16, 7:47 pm EST | Paul GallantGeneral Manager | 7,015 | $1.47 | $10,313 | 188,399 | — | plan? |
| Nov 16, 2017 FForm 4 → | Nov 16, 7:46 pm EST | Eric DavidCSO & EVP Pre-Clinical Dev | 5,625 | $1.47 | $8,270 | 876,609 | — | plan? |
| Nov 16, 2017 FForm 4 → | Nov 16, 7:45 pm EST | Jennifer BushGeneral Counsel & Secretary | 8,900 | $1.47 | $13,085 | 255,180 | — | plan? |
| Aug 16, 2017 FForm 4 → | Aug 17, 4:52 pm EDT | Sharon Collins PresnellChief Scientific Officer | 6,115 | $2.06 | $12,597 | 293,073 | — | plan? |
| Aug 16, 2017 FForm 4 → | Aug 17, 4:51 pm EDT | Craig KussmanChief Financial Officer | 26,362 | $2.06 | $54,306 | 325,638 | — | plan? |
| Aug 16, 2017 FForm 4 → | Aug 17, 4:50 pm EDT | Paul GallantGeneral Manager | 7,324 | $2.06 | $15,087 | 195,414 | — | plan? |
| Aug 16, 2017 FForm 4 → | Aug 17, 4:49 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 8,469 | $2.06 | $17,446 | 882,234 | — | plan? |
| Aug 16, 2017 FForm 4 → | Aug 17, 4:48 pm EDT | Jennifer BushGeneral Counsel & Secretary | 5,871 | $2.06 | $12,094 | 264,080 | — | plan? |
| Jun 27, 2017 AForm 4 → | Jun 29, 5:17 pm EDT | Sharon Collins PresnellChief Scientific Officer | 200,000 | — | — | 299,188 | — | plan? |
| Jun 27, 2017 AForm 4 → | Jun 29, 5:15 pm EDT | Craig KussmanChief Financial Officer | 220,000 | — | — | 352,000 | — | plan? |
| Jun 27, 2017 AForm 4 → | Jun 29, 5:14 pm EDT | Paul GallantGeneral Manager | 160,000 | — | — | 202,738 | — | plan? |
| Jun 27, 2017 AForm 4 → | Jun 29, 5:13 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 190,000 | — | — | 890,703 | — | plan? |
| Jun 27, 2017 AForm 4 → | Jun 29, 5:11 pm EDT | Jennifer BushGeneral Counsel & Secretary | 225,000 | — | — | 269,951 | — | plan? |
| May 16, 2017 FForm 4 → | May 17, 7:09 pm EDT | Paul GallantGeneral Manager | 1,317 | $2.86 | $3,769 | 42,738 | — | plan? |
| May 16, 2017 FForm 4 → | May 17, 7:07 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 1,263 | $2.86 | $3,615 | 700,703 | — | plan? |
| May 16, 2017 FForm 4 → | May 17, 7:06 pm EDT | Jennifer BushGeneral Counsel & Secretary | 1,235 | $2.86 | $3,535 | 44,951 | — | plan? |
| May 16, 2017 FForm 4 → | May 17, 7:05 pm EDT | Sharon Collins PresnellChief Scientific Officer | 1,167 | $2.86 | $3,340 | 99,188 | — | plan? |
| Mar 18, 2017 GForm 5 → | May 9, 6:06 pm EDT | Sharon Collins PresnellChief Scientific Officer | 15,000 | — | — | 100,355 | — | plan? |
| Feb 16, 2017 FForm 4 → | Feb 21, 6:02 pm EST | Sharon Collins PresnellChief Scientific Officer | 1,390 | $2.95 | $4,101 | 115,355 | — | plan? |
| Feb 16, 2017 FForm 4 → | Feb 21, 6:01 pm EST | Keith MurphyChairman, CEO and President, Director | 5,742 | $2.95 | $16,939 | 6,038,173 | — | plan? |
| Feb 16, 2017 FForm 4 → | Feb 21, 6:00 pm EST | Paul GallantGeneral Manager | 1,320 | $2.95 | $3,894 | 44,055 | — | plan? |
| Feb 16, 2017 FForm 4 → | Feb 21, 5:59 pm EST | Eric DavidCSO & EVP Pre-Clinical Dev | 1,390 | $2.95 | $4,101 | 701,966 | — | plan? |
| Feb 16, 2017 FForm 4 → | Feb 21, 5:57 pm EST | Jennifer BushGeneral Counsel & Secretary | 1,390 | $2.95 | $4,101 | 46,186 | — | plan? |
| Feb 14, 2017 GForm 5 → | May 9, 6:03 pm EDT | Keith MurphyDirector | 19,000 | — | — | 6,019,173 | — | plan? |
| Feb 9, 2017 SForm 4 → | Feb 10, 6:39 pm EST | Keith MurphyChairman, CEO and President, Director | 25,000 | $3.68 | $92,035 | 6,043,915 | −0.41% | plan? |
| Feb 8, 2017 MForm 4 → | Feb 10, 6:39 pm EST | Keith MurphyChairman, CEO and President, Director | 30,000 | $1.00 | $30,000 | 6,068,915 | — | plan? |
| Jan 23, 2017 SForm 4 → | Jan 25, 4:27 pm EST | Keith MurphyChairman, CEO and President, Director | 25,000 | $3.51 | $87,656 | 6,038,915 | −0.41% | plan? |
| Dec 14, 2016 SForm 4 → | Dec 15, 5:35 pm EST | Keith MurphyChairman, CEO and President, Director | 50,000 | $3.72 | $185,955 | 6,063,915 | −0.82% | plan? |
| Nov 16, 2016 FForm 4 → | Nov 18, 5:10 pm EST | Sharon Collins PresnellChief Scientific Officer | 1,210 | $3.26 | $3,944 | 116,745 | — | plan? |
| Nov 16, 2016 FForm 4 → | Nov 18, 5:08 pm EST | Keith MurphyChairman, CEO and President, Director | 7,200 | $3.26 | $23,468 | 6,113,915 | — | plan? |
| Nov 16, 2016 FForm 4 → | Nov 18, 5:07 pm EST | Paul GallantGeneral Manager | 1,160 | $3.26 | $3,781 | 45,375 | — | plan? |
| Nov 16, 2016 FForm 4 → | Nov 18, 5:06 pm EST | Eric DavidCSO & EVP Pre-Clinical Dev | 1,745 | $3.26 | $5,688 | 703,356 | — | plan? |
| Nov 16, 2016 FForm 4 → | Nov 18, 5:04 pm EST | Jennifer BushGeneral Counsel & Secretary | 1,210 | $3.26 | $3,944 | 47,576 | — | plan? |
| Sep 16, 2016 FForm 4 → | Sep 20, 5:02 pm EDT | Keith MurphyChairman, CEO and President, Director | 1,394 | $4.00 | $5,576 | 6,121,115 | — | plan? |
| Aug 23, 2016 AForm 4 → | Aug 23, 8:12 pm EDT | Craig KussmanChief Financial Officer | 132,000 | — | — | 132,000 | — | plan? |
| Aug 19, 2016 FForm 4 → | Aug 23, 8:14 pm EDT | Sharon Collins PresnellChief Scientific Officer | 1,109 | $4.00 | $4,438 | 117,955 | — | plan? |
| Aug 19, 2016 FForm 4 → | Aug 23, 8:13 pm EDT | Keith MurphyChairman, CEO and President, Director | 5,129 | $4.00 | $20,525 | 6,122,509 | — | plan? |
| Aug 19, 2016 FForm 4 → | Aug 23, 8:11 pm EDT | Paul GallantGeneral Manager | 965 | $4.00 | $3,862 | 46,535 | — | plan? |
| Aug 19, 2016 FForm 4 → | Aug 23, 8:10 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 1,205 | $4.00 | $4,822 | 705,101 | — | plan? |
| Aug 19, 2016 FForm 4 → | Aug 23, 8:09 pm EDT | Jennifer BushGeneral Counsel & Secretary | 1,214 | $4.00 | $4,858 | 48,786 | — | plan? |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:27 pm EDT | Richard E MarounDirector | 15,000 | — | — | 15,000 | — | plan? |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:26 pm EDT | Kirk MalloyDirector | 7,500 | — | — | 7,500 | — | plan? |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:25 pm EDT | Mark KesselDirector | 15,000 | — | — | 15,000 | — | plan? |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:24 pm EDT | Tamar D HowsonDirector | 7,500 | — | — | 7,500 | — | plan? |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:23 pm EDT | James T GloverDirector | 7,500 | — | — | 17,500 | — | plan? |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:22 pm EDT | Robert Baltera Jr.Director | 7,500 | — | — | 146,006 | — | plan? |
| Aug 5, 2016 SForm 4 → | Aug 9, 6:03 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 20,000 | $4.55 | $91,000 | 706,306 | −2.75% | plan? |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:06 pm EDT | Sharon Collins PresnellChief Scientific Officer | 50,000 | — | — | 119,064 | — | plan? |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:04 pm EDT | Keith MurphyChairman, CEO and President, Director | 208,000 | — | — | 6,127,638 | — | plan? |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:03 pm EDT | Paul GallantGeneral Manager | 47,500 | — | — | 47,500 | — | plan? |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:02 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 50,000 | — | — | 726,306 | — | plan? |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:01 pm EDT | Jennifer BushGeneral Counsel & Secretary | 50,000 | — | — | 50,000 | — | plan? |
| Mar 30, 2016 GForm 5 → | May 11, 7:54 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 5,000 | — | — | 676,306 | — | plan? |
| Feb 16, 2016 FForm 4 → | Feb 18, 7:01 pm EST | Keith MurphyChairman, CEO and President, Director | 24,690 | $2.04 | $50,368 | 5,919,638 | — | plan? |
| Sep 21, 2015 SForm 4 → | Sep 23, 7:22 pm EDT | Robert Baltera Jr.Director | 6,000 | $4.03 | $24,193 | 138,506 | −4.15% | plan? |
| Aug 31, 2015 GForm 5 → | May 11, 2016, 7:56 pm EDT | Barry D MichaelsChief Financial Officer | 86,808 | — | — | 0 | — | plan? |
| Aug 24, 2015 FForm 4 → | Aug 24, 8:31 pm EDT | Barry D MichaelsChief Financial Officer | 100,692 | $2.32 | $233,605 | 86,808 | — | plan? |
| Aug 13, 2015 PForm 4 → | Aug 13, 8:12 pm EDT | James T GloverDirector | 10,000 | $2.80 | $28,000 | 10,000 | — | plan? |
| Aug 12, 2015 PForm 4 → | Aug 13, 8:10 pm EDT | Keith MurphyChairman, CEO and President, Director | 20,000 | $2.56 | $51,188 | 5,944,328 | +0.34% | plan? |
| Mar 12, 2015 MForm 4 → | Mar 16, 5:19 pm EDT | Sharon Collins PresnellEVP, Research & Dev & CTO | 50,000 | $0.08 | $4,000 | 74,064 | — | plan? |
| Feb 13, 2015 FForm 4 → | Feb 18, 7:04 pm EST | Keith MurphyChairman, CEO and President, Director | 28,008 | $6.34 | $177,571 | 5,961,328 | — | plan? |
| Sep 10, 2014 GForm 5 → | Jul 9, 2015, 6:59 pm EDT | Sharon Collins PresnellEVP, Research & Dev & CTO | 5,000 | — | — | 69,064 | — | plan? |
| Jul 9, 2014 GForm 5 → | Jul 9, 2015, 7:01 pm EDT | Keith MurphyChairman, CEO and President, Director | 37,000 | — | — | 5,924,328 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2018 AForm 4 → | Dec 6, 4:34 pm EST | David ShapiroDirector | 76,500 | — | — | 30,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 7:03 pm EDT | Sharon Collins PresnellChief Scientific Officer | 675,000 | — | — | 675,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 7:02 pm EDT | Craig KussmanChief Financial Officer | 675,000 | — | — | 675,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 7:00 pm EDT | Taylor CrouchCEO & President, Director | 1,350,000 | — | — | 1,350,000 | — | |
| Aug 15, 2018 AForm 4 → | Aug 16, 6:58 pm EDT | Jennifer BushGeneral Counsel & Secretary | 675,000 | — | — | 675,000 | — | |
| Aug 14, 2018 AForm 4 → | Aug 15, 7:04 pm EDT | Steven George HughesChief Medical Officer | 974,694 | — | — | 974,694 | — | |
| Jul 26, 2018 AForm 4 → | Jul 30, 4:58 pm EDT | Richard E MarounDirector | 45,500 | — | — | 45,550 | — | |
| Jul 26, 2018 AForm 4 → | Jul 30, 4:56 pm EDT | Kirk MalloyDirector | 45,500 | — | — | 45,550 | — | |
| Jul 26, 2018 AForm 4 → | Jul 30, 4:55 pm EDT | Mark KesselDirector | 45,500 | — | — | 45,550 | — | |
| Jul 26, 2018 AForm 4 → | Jul 30, 4:54 pm EDT | Tamar D HowsonDirector | 45,500 | — | — | 45,550 | — | |
| Jul 26, 2018 AForm 4 → | Jul 30, 4:52 pm EDT | James T GloverDirector | 45,500 | — | — | 45,550 | — | |
| Jul 26, 2018 AForm 4 → | Jul 30, 4:51 pm EDT | Robert Baltera Jr.Director | 45,500 | — | — | 45,550 | — | |
| May 24, 2018 AForm 4 → | May 29, 5:44 pm EDT | Sharon Collins PresnellChief Scientific Officer | 300,000 | — | — | 300,000 | — | |
| May 24, 2018 AForm 4 → | May 29, 5:42 pm EDT | Craig KussmanChief Financial Officer | 300,000 | — | — | 300,000 | — | |
| May 24, 2018 AForm 4 → | May 29, 5:39 pm EDT | Paul GallantGeneral Manager | 266,667 | — | — | 266,667 | — | |
| May 24, 2018 AForm 4 → | May 29, 5:37 pm EDT | Taylor CrouchCEO & President, Director | 600,000 | — | — | 600,000 | — | |
| May 24, 2018 AForm 4 → | May 29, 5:36 pm EDT | Jennifer BushGeneral Counsel & Secretary | 283,333 | — | — | 283,333 | — | |
| Aug 24, 2017 AForm 4 → | Aug 28, 4:39 pm EDT | Richard E MarounDirector | 42,500 | — | — | 42,500 | — | |
| Aug 24, 2017 AForm 4 → | Aug 28, 4:38 pm EDT | Kirk MalloyDirector | 42,500 | — | — | 42,500 | — | |
| Aug 24, 2017 AForm 4 → | Aug 28, 4:36 pm EDT | Mark KesselDirector | 42,500 | — | — | 42,500 | — | |
| Aug 24, 2017 AForm 4 → | Aug 28, 4:35 pm EDT | Tamar D HowsonDirector | 42,500 | — | — | 42,500 | — | |
| Aug 24, 2017 AForm 4 → | Aug 28, 4:33 pm EDT | James T GloverDirector | 42,500 | — | — | 42,500 | — | |
| Aug 24, 2017 AForm 4 → | Aug 28, 4:32 pm EDT | Robert Baltera Jr.Director | 42,500 | — | — | 42,500 | — | |
| Apr 24, 2017 AForm 4 → | Apr 24, 5:27 pm EDT | Taylor CrouchCEO & President, Director | 2,088,212 | — | — | 2,088,212 | — | |
| Feb 8, 2017 MForm 4 → | Feb 10, 6:39 pm EST | Keith MurphyChairman, CEO and President, Director | 30,000 | — | — | 0 | — | |
| Aug 23, 2016 AForm 4 → | Aug 23, 8:12 pm EDT | Craig KussmanChief Financial Officer | 330,000 | — | — | 330,000 | — | |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:27 pm EDT | Richard E MarounDirector | 37,000 | — | — | 18,500 | — | |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:26 pm EDT | Kirk MalloyDirector | 18,500 | — | — | 18,500 | — | |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:25 pm EDT | Mark KesselDirector | 37,000 | — | — | 18,500 | — | |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:24 pm EDT | Tamar D HowsonDirector | 18,500 | — | — | 18,500 | — | |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:23 pm EDT | James T GloverDirector | 18,500 | — | — | 18,500 | — | |
| Aug 17, 2016 AForm 4 → | Aug 19, 6:22 pm EDT | Robert Baltera Jr.Director | 18,500 | — | — | 18,500 | — | |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:06 pm EDT | Sharon Collins PresnellChief Scientific Officer | 100,000 | — | — | 100,000 | — | |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:04 pm EDT | Keith MurphyChairman, CEO and President, Director | 415,000 | — | — | 415,000 | — | |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:03 pm EDT | Paul GallantGeneral Manager | 95,000 | — | — | 95,000 | — | |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:02 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 100,000 | — | — | 100,000 | — | |
| Jul 11, 2016 AForm 4 → | Jul 13, 8:01 pm EDT | Jennifer BushGeneral Counsel & Secretary | 100,000 | — | — | 100,000 | — | |
| Feb 16, 2016 AForm 4 → | Feb 18, 7:01 pm EST | Keith MurphyChairman, CEO and President, Director | 24,690 | — | — | 24,690 | — | |
| Aug 24, 2015 AForm 4 → | Aug 24, 8:31 pm EDT | Barry D MichaelsChief Financial Officer | 100,692 | — | — | 100,692 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 8:27 pm EDT | Kirk MalloyDirector | 37,000 | — | — | 37,000 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 8:22 pm EDT | Tamar D HowsonDirector | 37,000 | — | — | 37,000 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 8:20 pm EDT | Richard A. HeymanDirector | 37,000 | — | — | 37,000 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 8:19 pm EDT | James T GloverDirector | 37,000 | — | — | 37,000 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 8:15 pm EDT | Robert Baltera Jr.Director | 37,000 | — | — | 37,000 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 8:14 pm EDT | Paul GallantGeneral Manager | 225,000 | — | — | 225,000 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 7:38 pm EDT | Michael RenardEVP of Commercial Operations | 130,000 | — | — | 130,000 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 7:36 pm EDT | Sharon Collins PresnellEVP, Research & Dev & CTO | 130,000 | — | — | 130,000 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 7:31 pm EDT | Keith MurphyChairman, CEO and President, Director | 465,000 | — | — | 465,000 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 7:28 pm EDT | Barry D MichaelsChief Financial Officer | 255,000 | — | — | 255,000 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 7:23 pm EDT | Eric DavidCSO & EVP Pre-Clinical Dev | 130,000 | — | — | 130,000 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 7:19 pm EDT | Jennifer BushGeneral Counsel | 125,000 | — | — | 125,000 | — | |
| Mar 12, 2015 MForm 4 → | Mar 16, 5:19 pm EDT | Sharon Collins PresnellEVP, Research & Dev & CTO | 50,000 | — | — | 622,192 | — | |
| Feb 13, 2015 AForm 4 → | Feb 18, 7:04 pm EST | Keith MurphyChairman, CEO and President, Director | 28,008 | — | — | 28,008 | — | |
| Aug 15, 2008 AForm 4 → | Aug 16, 2018, 7:01 pm EDT | Paul GallantGeneral Manager | 450,000 | — | — | 450,000 | — | late |